Spire Wealth Management reduced its position in Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX – Get Rating ) by 3.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 21,100 shares of the pharmaceutical company's stock after selling 676 shares during the quarter. Spire Wealth Management's holdings in Vertex Pharmaceuticals were worth $6,093,000 at the end of the most recent quarter. Other hedge funds and other institutional investors have also recently modified their holdings of the company.

https://www.dailypolitical.com/2023/04/20/spire-wealth-management-cuts-stock-position-in-vertex-pharmaceuticals-incorporated-nasdaqvrtx.html

#dailypolitical